Daily BriefsECM

Daily Brief ECM: CTG Duty-Free H-Share Listing: Thoughts on First Day Trading and more

In today’s briefing:

  • CTG Duty-Free H-Share Listing: Thoughts on First Day Trading
  • CTG Duty Free H Share Listing: Trading Debut
  • Leapmotor IPO: The Bear Case
  • Go Digit General Insurance Pre-IPO Tearsheet
  • Concord Biotech Pre-IPO Tearsheet

CTG Duty-Free H-Share Listing: Thoughts on First Day Trading

By Shifara Samsudeen, ACMA, CGMA

  • CTG Duty-Free Group has priced its IPO at HK$158 per share, at a slight premium to the midpoint of the indicative IPO price range of HK$143.5-165.5 per share.
  • At HK$158 per share, the company raised net proceeds of HK$15,892.3 (approx. US$2.0bn) and the IPO is priced at an almost 30% discount to CTG’s A-share last close price.
  • Cornerstone investors subscribed for approx. 38.4% of the H-share offering (or 1.9% of the total issued share capital of the company post-offering) with some existing shareholders subscribing under placing guidelines.

CTG Duty Free H Share Listing: Trading Debut

By Arun George


Leapmotor IPO: The Bear Case

By Arun George

  • Leapmotor (2007699D HK), a Chinese EV manufacturer, will start its listing hearing for a US$1.5 billion HKEx IPO this week, according to press reports.
  • In Leapmotor IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case. 
  • The key elements of the bear case rest on a slow ramp-up, lower revenue, high EBIT and FCF loss margin compared to peers at a similar stage of development.

Go Digit General Insurance Pre-IPO Tearsheet

By Ethan Aw

  • Go Digit General Insurance (1643133D IN) is looking to raise about US$503m in its upcoming India IPO. The deal will be run by ICICI, MS, Axis, Edelweiss, HDFC and IIFL. 
  • Go Digit General Insurance (GDGI) is a digital full stack insurance company, offering motor, health, travel, property, marine, liability and other insurance products, which are customizable, as per the company. 
  • GDGI accounted for approximately 82.9% (INR 52.68bn in Fiscal 2022) of the gross written premiums written, making it the largest digital full stack insurance player in India, according to RedSeer.

Concord Biotech Pre-IPO Tearsheet

By Clarence Chu

  • Concord Biotech Ltd (658823Z IN) is looking to raise about US$250m in its upcoming India IPO. The deal will be run by Kotak, Citi, and Jefferies.
  • Concord Biotech is an India-based biopharma firm, which develops and manufactures fermentation-based APIs.
  • As per F&S, it was one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on FY21 volume.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars